Blog Post

Stewardship Over Automation: FDA Redefines AI Accountability in Pharma

In response to a landmark FDA warning, this analysis explores how regulators are shifting from automation to accountable stewardship, redefining governance expectations for AI across...

Read More

Blog Post

The FDA Just Flipped the Switch on Agentic AI – And CAI is Ready! 

How digital regulation will reshape quality, compliance and operational expectations across the life sciences ecosystem. Written by: Cassidy Reid & Alice Redmond A Regulator Moving...

Read More

Blog Post

Navigating Regulatory Complexity in Life Sciences: Turning Compliance into a Strategic Advantage 

As global regulations continue to evolve, life sciences companies are facing increasing pressure to meet stringent compliance requirements without slowing down innovation or compromising product...

Read More